Cargando…
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm an...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230641/ https://www.ncbi.nlm.nih.gov/pubmed/34208059 http://dx.doi.org/10.3390/vaccines9060642 |
_version_ | 1783713259040276480 |
---|---|
author | Peterhoff, David Thalhauser, Stefanie Sobczak, Jan M. Mohsen, Mona O. Voigt, Christoph Seifert, Nicole Neckermann, Patrick Hauser, Alexandra Ding, Song Sattentau, Quentin Bachmann, Martin F. Breunig, Miriam Wagner, Ralf |
author_facet | Peterhoff, David Thalhauser, Stefanie Sobczak, Jan M. Mohsen, Mona O. Voigt, Christoph Seifert, Nicole Neckermann, Patrick Hauser, Alexandra Ding, Song Sattentau, Quentin Bachmann, Martin F. Breunig, Miriam Wagner, Ralf |
author_sort | Peterhoff, David |
collection | PubMed |
description | The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm and 200 nm silica nanoparticles (SiNPs) to optimize conjugation density and attachment stability. Env was redesigned to enable site-specific cysteine-mediated covalent conjugation while maintaining its structural integrity and antigenicity. Env was anchored to different sized SiNPs with a calculated spacing of 15 nm between adjacent trimers. Both particle sizes exhibited high in vitro stability over a seven-day period. After attachment, 100 nm particles showed better colloidal stability compared to 200 nm particles. Importantly, the antigenic profile of Env was not impaired by surface attachment, indicating that the quaternary structure was maintained. In vitro Env uptake by dendritic cells was significantly enhanced when Env was delivered on the surface of nanoparticles compared to soluble Env. Furthermore, multivalent Env displayed efficiently activated B cells even at Env concentrations in the low nanomolar range. In mice, antibody responses to nanoparticle-coupled Env were stronger compared to the free protein and had equivalent effects at lower doses and without adjuvant. |
format | Online Article Text |
id | pubmed-8230641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82306412021-06-26 Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery Peterhoff, David Thalhauser, Stefanie Sobczak, Jan M. Mohsen, Mona O. Voigt, Christoph Seifert, Nicole Neckermann, Patrick Hauser, Alexandra Ding, Song Sattentau, Quentin Bachmann, Martin F. Breunig, Miriam Wagner, Ralf Vaccines (Basel) Article The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm and 200 nm silica nanoparticles (SiNPs) to optimize conjugation density and attachment stability. Env was redesigned to enable site-specific cysteine-mediated covalent conjugation while maintaining its structural integrity and antigenicity. Env was anchored to different sized SiNPs with a calculated spacing of 15 nm between adjacent trimers. Both particle sizes exhibited high in vitro stability over a seven-day period. After attachment, 100 nm particles showed better colloidal stability compared to 200 nm particles. Importantly, the antigenic profile of Env was not impaired by surface attachment, indicating that the quaternary structure was maintained. In vitro Env uptake by dendritic cells was significantly enhanced when Env was delivered on the surface of nanoparticles compared to soluble Env. Furthermore, multivalent Env displayed efficiently activated B cells even at Env concentrations in the low nanomolar range. In mice, antibody responses to nanoparticle-coupled Env were stronger compared to the free protein and had equivalent effects at lower doses and without adjuvant. MDPI 2021-06-11 /pmc/articles/PMC8230641/ /pubmed/34208059 http://dx.doi.org/10.3390/vaccines9060642 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Peterhoff, David Thalhauser, Stefanie Sobczak, Jan M. Mohsen, Mona O. Voigt, Christoph Seifert, Nicole Neckermann, Patrick Hauser, Alexandra Ding, Song Sattentau, Quentin Bachmann, Martin F. Breunig, Miriam Wagner, Ralf Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery |
title | Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery |
title_full | Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery |
title_fullStr | Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery |
title_full_unstemmed | Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery |
title_short | Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery |
title_sort | augmenting the immune response against a stabilized hiv-1 clade c envelope trimer by silica nanoparticle delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230641/ https://www.ncbi.nlm.nih.gov/pubmed/34208059 http://dx.doi.org/10.3390/vaccines9060642 |
work_keys_str_mv | AT peterhoffdavid augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT thalhauserstefanie augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT sobczakjanm augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT mohsenmonao augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT voigtchristoph augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT seifertnicole augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT neckermannpatrick augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT hauseralexandra augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT dingsong augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT sattentauquentin augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT bachmannmartinf augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT breunigmiriam augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery AT wagnerralf augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery |